ADVANCED CHOLANGIOCARCINOMA
Clinical trials for ADVANCED CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Groundbreaking pill trial offers hope for tough liver cancers
Disease control Recruiting nowThis is the first human study of an experimental oral medication called AU409 for people with advanced liver cancers or other solid tumors that have spread to the liver. The main goal is to find the safest and most effective dose by testing it in a small group of patients whose c…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New Triple-Drug attack on tough bile duct cancer begins human testing
Disease control Recruiting nowThis study is testing a new combination of three drugs to see if they can help control advanced bile duct cancer (cholangiocarcinoma) that has a specific genetic change called an FGFR2 fusion. The trial will enroll about 25 adults whose cancer has progressed after standard treatm…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Cancer care comes home: mayo clinic tests house calls for treatment
Disease control Recruiting nowThis study is testing whether giving standard cancer treatments at home is as safe and effective as giving them in a clinic. It aims to see if receiving care at home reduces stress, improves quality of life, and is preferred by patients with advanced cancers. About 220 participan…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New targeted pill tested for Tough-to-Treat bile duct cancer
Disease control Recruiting nowThis study is testing two different daily doses of an oral drug called futibatinib for people with advanced bile duct cancer (cholangiocarcinoma) that has a specific genetic change called an FGFR2 fusion or rearrangement. The goal is to see if a lower dose (16 mg) is as safe and …
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC